H

HBM Holdings
2142

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
HK$6.73B
EV
HK$5.91B
Shares Outstanding
793.71M
Beta
1.71

Wall Street View

Analyst Rating
BUY
Analyst Target Price
HK$1.55
P/E 2025E
13.17x
P/Revenue 2025E
5.52x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About HBM Holdings Limited

gainify

H

HBM Holdings Limited

2142

HBM Holdings Limited, a clinical-stage biopharmaceutical company, engages in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas. The company has developed the Harbour Mice Platform, which generates fully huma...

Sector

Healthcare

Industry

Biotechnology

CEO

Wang, Jingsong

Employees

183

IPO Date

2020-12-10

Headquarters

Building A3, Suite 202, 218 Xinghu Street, Suzhou Industrial Park, Suzhou, Jiangsu Province, 215123, China

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.